Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

3 mars 2021 uppdaterad av: John Holland, OHSU Knight Cancer Institute

Integrating Tobacco Cessation Coaching Sessions Into Radiation Medicine Treatment: A Pilot Study

This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources may help doctors understand how health care providers can effectively increase their confidence in talking to patients about tobacco cessation counseling.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

PRIMARY OBJECTIVES:

I. To determine if training providers on tobacco cessation resources increases the frequency of counseling and referrals at initial and follow-up consultations for cancer patients who use tobacco and are scheduled to receive radiation at Oregon Health and Science University (OHSU).

SECONDARY OBJECTIVES:

I. Increase provider frequency of tobacco use quantification and type. II. Increase frequency of provider assessment of tobacco cessation readiness in current users.

III. Increase frequency and types of tobacco cessation resources and medicines offered and utilized.

IV. Increase frequency and type of follow-up planned if referred to cessation resource.

OUTLINE:

MEDICAL CHART REVIEW: Medical charts from patients with diagnoses of head and neck cancer, lung cancer, prostate cancer, or breast cancer are reviewed at months 1-12 to determine the frequency of tobacco assessments and documentation of discussions with patients regarding tobacco use and utilization of cessation resources as before and after the proposed training.

PROVIDER TRAINING: Providers undergo training to use patient coaching such as the 5A's (Ask, Advise, Assess, Assist, and Arrange), to conduct regular tobacco intake assessment using motivational interviewing techniques. Providers also undergo training to use public/community tobacco cessation resources for patients ready to quit within six weeks, and have access to pharmacy residents for ad-hoc prescribing questions.

PATIENT COACHING: Patients attend 4 phone or in-person motivational interviewing coaching sessions over 30-45 minutes for 6-8 weeks or longer as needed.

Studietyp

Interventionell

Inskrivning (Faktisk)

2

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

  • Förenta staterna
    • Oregon
      • Portland, Oregon, Förenta staterna, 97239
        • OHSU Knight Cancer Institute

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • MEDICAL CHART REVIEW
  • Pre-intervention: 200 patient records between January 1, 2016 and December 31, 2016 are subject to review; the first 50 records with a diagnoses of each cancer type: head and neck, lung, prostate, or breast will be utilized for the review
  • Post-intervention: 200 patient records receiving care beginning six months post training are subject to review; the first 50 records with a diagnoses of head and neck, lung, prostate, or breast will be utilized
  • PROVIDER TRAINING
  • OHSU Radiation Medicine department has agreed to participate as pilot department for this project; all active Radiation Medicine providers are requested to participate in the training; providers have the option to not participate
  • TOBACCO CESSATION COACHING
  • Patients who are at least 18 years of age
  • Speak English
  • Report tobacco use within the past 7 days
  • Willing to consider quitting smoking
  • Patients must be willing to meet four times in person or on the phone to discuss tobacco use
  • Patients must be willing to be audio recorded during the sessions
  • Patients who meet this criteria will be referred to OHSU Health Promotion Sports Medicine researcher, Carol DeFrancesco, to complete assessment using stages of change tobacco use readiness ruler and question set
  • Patient smoking status will be documented in their electronic health record, per routine care

Exclusion Criteria:

  • Vulnerable Populations

    • The following groups will be excluded from participation:

      • Children
      • Decisionally impaired adults
      • Prisoners
      • Pregnant women

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Hälsovårdsforskning
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Health Services Research (Chart review, training, coaching)

MEDICAL CHART REVIEW: Medical charts from patients with diagnoses of head and neck cancer, lung cancer, prostate cancer, or breast cancer are reviewed at months 1-12 to determine the frequency of tobacco assessments and documentation of discussions with patients regarding tobacco use and utilization of cessation resources as before and after the proposed training.

PROVIDER TRAINING: Providers undergo training to use patient coaching such as the 5A's (Ask, Advise, Assess, Assist, and Arrange), to conduct regular tobacco intake assessment using motivational interviewing techniques. Providers also undergo training to use public/community tobacco cessation resources for patients ready to quit within six weeks, and have access to pharmacy residents for ad-hoc prescribing questions.

PATIENT COACHING: Patients attend 4 phone or in-person motivational interviewing coaching sessions over 30-45 minutes for 6-8 weeks or longer as needed.
Övrig: Enkätadministration
Sidostudier
Övrig: Communication Skills Training
Undergo motivational interviewing training
Övrig: Medical Chart Review
Undergo medical chart review
Andra namn:
  • Kartgranskning
Övrig: Tobacco Cessation Counseling
Attend phone or in-person motivational interviewing coaching sessions

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in frequency of tobacco counsel
Tidsram: Baseline up to 24 months
Will be compared between the cohort of pre and post intervention. Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Baseline up to 24 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in frequency and type of follow-up planned if referred to cessation resource assessed by medical chart review
Tidsram: Baseline up to 24 months
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Baseline up to 24 months
Change in frequency and types of tobacco cessation resources and medicines offered and utilized assessed by medical chart review
Tidsram: Baseline up to 24 months
Will be tested using a chi-squared test. If any expected cell count in the contingency table is lower than 5, we will instead use Fisher's exact test.
Baseline up to 24 months
Change in frequency of provider assessment of tobacco cessation readiness in current users assessed by medical chart review
Tidsram: Baseline up to 24 months
Will be summarized using descriptive statistics and compared using chi-square test by tumor type.
Baseline up to 24 months
Change in provider frequency of tobacco use quantification and type assessed by medical chart review
Tidsram: Baseline up to 24 months
Will be summarized using descriptive statistics and compared using chi-square test by tumor type. Will be tested using Z tests of proportion.
Baseline up to 24 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

OHSU Knight Cancer Institute

Samarbetspartners

Oregon Health and Science University

Utredare

  • Huvudutredare: John Holland, OHSU Knight Cancer Institute

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 augusti 2017

Primärt slutförande (Faktisk)

23 september 2020

Avslutad studie (Faktisk)

23 september 2020

Studieregistreringsdatum

Först inskickad

26 april 2017

Först inskickad som uppfyllde QC-kriterierna

26 april 2017

Första postat (Faktisk)

1 maj 2017

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

5 mars 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 mars 2021

Senast verifierad

1 mars 2021

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • STUDY00016428 (Annan identifierare: OHSU Knight Cancer Institute)
  • NCI-2017-00576 (Registeridentifierare: CTRP (Clinical Trial Reporting Program))

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Användning av tobak

Kliniska prövningar på Enkätadministration

Sök liknande försök

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

CROs by country

CROs in Mozambique

Betingelser

Sällsynta sjukdomar

Läkemedelsinterventioner

Kosttillskott

Sponsor / medarbetare

Platser

Prenumerera